Skip to main content

Rhenman & Partners Asset Management AB

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1599882 Stockholm, V7

Position in IOVA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,094,160
-$120,037 QoQ
Shares Held
1,705,327
-17.0% QoQ
Ownership
0.376%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#31
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. IOVA ranks #21 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,094,160 1,705,327
2026-03-31 $7,214,197 2,055,327
2025-12-31 $4,355,242 1,595,327
2025-09-30 $2,382,284 1,097,827
2025-06-30 $1,114,262 647,827
2025-03-31 $2,157,263 647,827
2024-12-31 $9,142,315 1,235,448
2024-09-30 $9,882,975 1,052,500
2024-06-30 $7,378,400 920,000
2024-03-31 $14,153,100 955,000
2023-12-31 $9,079,730 1,116,818
2023-09-30 $4,322,500 950,000
2023-06-30 $5,984,000 850,000
2023-03-31 $4,192,498 686,170
2022-12-31 $5,523,375 864,378
2022-09-30 $4,885,800 510,000
2022-06-30 $5,851,200 530,000
2022-03-31 $7,908,750 475,000
2021-12-31 $11,454,000 600,000
2021-09-30 $7,891,200 320,000
2021-06-30 $7,806,000 300,000
2021-03-31 $9,339,700 295,000
2020-12-31 $14,848,000 320,000
2020-09-30 $11,192,800 340,000
2020-06-30 $9,333,000 340,000
2020-03-31 $10,928,100 365,000